Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

Autor: Blum K; Center for Psychiatry, Medicine & Primary Care (Office of the Provost), Division of Addiction Research & Education, Western University Health Science, Pomona, CA 91766, USA.; Institute of Psychology, ELTE Eötvös Loránd University, Kazinczy u. 23-27, 1075 Budapest, Hungary.; Division of Nutrigenomics, Genomic Testing Center Geneus Health, San Antonio, TX 78249, USA.; Department of Psychiatry, University of Vermont, Burlington, VT 05401, USA.; Department of Psychiatry, Wright University Boonshoff School of Medicine, Dayton, OH 45377, USA.; Division of Precision Nutrition, Victory Nutrition International, Bonita Springs, FL 34135, USA.; The Kenneth Blum Behavioral & Neurogenetic Institute, Division of Ivitalize Inc., Austin, TX 78701, USA.; Division of Clinical Neurology, Path Foundation NY, New York, NY 10010, USA., Gold MS; Department of Psychiatry, School of Medicine, Tulane University, New Orleans, LA 70118, USA., Llanos-Gomez L; The Kenneth Blum Behavioral & Neurogenetic Institute, Division of Ivitalize Inc., Austin, TX 78701, USA., Jalali R; The Kenneth Blum Behavioral & Neurogenetic Institute, Division of Ivitalize Inc., Austin, TX 78701, USA., Thanos PK; Department of Psychology & Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions (BNNLA), Research Institute on Addictions, University at Buffalo, Buffalo, NY 14260, USA., Bowirrat A; Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel., Downs WB; Division of Precision Nutrition, Victory Nutrition International, Bonita Springs, FL 34135, USA., Bagchi D; Division of Precision Nutrition, Victory Nutrition International, Bonita Springs, FL 34135, USA.; Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, Texas Southern University, Houston, TX 77004, USA., Braverman ER; Division of Clinical Neurology, Path Foundation NY, New York, NY 10010, USA., Baron D; Center for Psychiatry, Medicine & Primary Care (Office of the Provost), Division of Addiction Research & Education, Western University Health Science, Pomona, CA 91766, USA., Roy AK 3rd; Department of Psychiatry, School of Medicine, Tulane University, New Orleans, LA 70118, USA., Badgaiyan RD; Department of Psychiatry, South Texas Veteran Health Care System, Audie L. Murphy Memorial VA Hospital, Long School of Medicine, University of Texas Medical Center, San Antonio, TX 78249, USA.

Publikováno v: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 Sep 16; Vol. 18 (18). Date of Electronic Publication: 2021 Sep 16.

A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone.

Autor: Blum K; a Department of Psychiatry & McKnight Brain Institute , University of Florida College of Medicine , Gainesville , Florida , USA.; b Division of Addiction Services , Dominion Diagnostics, LLC , North Kingstown , Rhode Island , USA.; c Departments of Psychiatry & Behavioral Sciences , Keck School of Medicine of USC , Los Angeles , California , USA.; d Department of Psychology , Eötvös Loránd University, Institute of Psychology , Budapest , Hungary.; e Human Integrated Services Unit , University of Vermont Centre for Clinical & Translational Science, College of Medicine , Burlington , Vermont , USA.; f Division of Neuroscience Research & Addiction Therapy , Shores Treatment & Recovery Center , Port Saint Lucie , Florida , USA.; g Geneus Health , San Antonio , Texas , USA., Han D; h Department of Management Science and Statistics , University of Texas at San Antonio , Texas , USA., Modestino EJ; i Department of Psychology , Curry College , Milton , Massachusetts , USA., Saunders S; b Division of Addiction Services , Dominion Diagnostics, LLC , North Kingstown , Rhode Island , USA., Roy AK 3rd; j Behavioral Medical Corporation , Metairie , Louisiana , USA., Jacobs W; k Division of Addiction Medicine , Medical College of Georgia , Augusta , Georgia , USA., Inaba DS; l Division of Alcohol & Drug Studies , University of Utah , Salt Lake City , Utah , USA., Baron D; c Departments of Psychiatry & Behavioral Sciences , Keck School of Medicine of USC , Los Angeles , California , USA., Oscar-Berman M; n Department of Psychiatry, Neurology, Anatomy & Neurobiology , Boston University School of Medicine, & VA Boston Healthcare System , Boston , Massachusetts , USA., Hauser M; b Division of Addiction Services , Dominion Diagnostics, LLC , North Kingstown , Rhode Island , USA., Badgaiyan RD; m Department of Psychiatry , Icahn School of Medicine , New York , New York , USA., Smith DE; p Department of Pharmacology , University of San Francisco , San Francisco , California , USA., Femino J; b Division of Addiction Services , Dominion Diagnostics, LLC , North Kingstown , Rhode Island , USA., Gold MS; o Department of Psychiatry , Washington University School of Medicine , St. Louis , Missouri , USA.

Publikováno v: Substance use & misuse [Subst Use Misuse] 2018 Jan 28; Vol. 53 (2), pp. 220-229. Date of Electronic Publication: 2017 Dec 19.

Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation.

Autor: Blum K; 1 Department of Psychiatry and McKnight Brain Institute, University of Florida , College of Medicine, Gainesville, Florida., Febo M, Smith DE, Roy AK 3rd, Demetrovics Z, Cronjé FJ, Femino J, Agan G, Fratantonio JL, Pandey SC, Badgaiyan RD, Gold MS

Publikováno v: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2015 May; Vol. 25 (4), pp. 286-92. Date of Electronic Publication: 2015 Apr 28.